Provided by Tiger Fintech (Singapore) Pte. Ltd.

AxoGen

9.47
-0.2600-2.67%
Volume:145.08K
Turnover:1.39M
Market Cap:431.30M
PE:-59.16
High:9.77
Open:9.71
Low:9.35
Close:9.73
Loading ...

AxoGen Inc : Raymond James Raises Target Price to $23 From $18

THOMSON REUTERS
·
19 Feb

We Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) Soon

Simply Wall St.
·
18 Feb

Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025

GlobeNewswire
·
12 Feb

AxoGen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Feb

Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 Feb

Axogen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
03 Feb

U.S. RESEARCH ROUNDUP-Abbvie, Comstock Resources, Sherwin-Williams

Reuters
·
03 Feb

Is Axogen (NASDAQ:AXGN) Using Too Much Debt?

Simply Wall St.
·
15 Jan

Stock Track | AxoGen Soars 5.83% After-Hours as Medical Device Maker Hits New Highs

Stock Track
·
14 Jan

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?

Zacks
·
13 Jan

AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?

Zacks
·
13 Jan

BRIEF-Axogen Announces New VP Of Operations And Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
11 Jan

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
11 Jan

Axogen Reports Preliminary Q4 Revenue $49.4M, Up 15.1% YoY; FY24 Revenue $187.3M, Up 17.8% YoY; Expect Full Year Gross Margin To Be Above 75.5%

Benzinga
·
10 Jan

AxoGen Q4 Revenue USD 49.4 Million VS. Ibes Estimate USD 47.6 Million

THOMSON REUTERS
·
10 Jan

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024

GlobeNewswire
·
10 Jan

AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?

Zacks
·
24 Dec 2024